ImmunoGen Inc (IMGN)

US45253H1014 - Common Stock

31.23  0 (0%)

After market: 31.24 +0.01 (+0.03%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
132.3M
60.75%		69.9M
-47.17%		108.8M
55.65%		384.16M
253.09%
EBITDA
YoY % growth
-18.8M
71.84%		-123.08M
-554.68%		-219.12M
-78.03%		-133.62M
39.02%		N/AN/AN/A
EBIT
YoY % growth
-20.9M
70.48%		-125.1M
-498.56%		-220.9M
-76.58%		15.273M
106.91%
Operating Margin
-15.80%-178.97%-203.03%3.98%
EPS
YoY % growth
-0.28
60.56%		-0.67
-139.29%		-0.88
-31.34%		0.08
108.78%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26
EPS
Q2Q % growth		0.13
157.18%
Revenue
Q2Q % growth		132.82M
222.38%
EBITDA
Q2Q % growth		30.753MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		38.124M
163.97%		N/AN/AN/AN/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2023
Q2Q % growth		 0.10
132.26%		0.050.05119.72%
Q2 2023
Q2Q % growth		 -0.02
91.67%		-0.140.1285.91%
Q1 2023
Q2Q % growth		 -0.16
-60.00%		-0.250.0937.05%
Q4 2022
Q2Q % growth		 -0.23
-35.29%		-0.300.0723.99%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2023
Q2Q % growth		 113.4M
636.36%		108.54M4.86M4.48%
Q2 2023
Q2Q % growth		 83.2M
485.92%		49.316M33.884M68.71%
Q1 2023
Q2Q % growth		 49.9M
30.97%		20.881M29.019M138.97%
Q4 2022
Q2Q % growth		 41.2M
47.14%		17.597M23.603M134.13%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 10.27% 6.14% 223.03%
Revenue0% 2.12% 0.2% 7.31%